MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Quick Stats
Mar 30, 202656.1
AI Score
HOLD0.31
Volume Ratio
May 11, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
MLTX Stock Summary
Last updated
MLTX is currently trading at $16.77, positioned below its 200-day moving average of $28.12, suggesting bearish momentum. The stock has a 52-week range of $5.95 to $62.75.
Technical Analysis: The 50-day moving average stands at $16.88, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MLTX at 56.1/100 with a HOLD recommendation.
MLTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MLTX Price vs Max Options Open Interest
MLTX Max Change In Options Open Interest
MLTX Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLTX Daily Out of Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLTX Daily In the Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLTX Most Active Options by Volume(near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MoonLake Immunotherapeutics Class A Ordinary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
MLTX Moving Averages Analysis
MLTX (MoonLake Immunotherapeutics Class A Ordinary Shares) Simple Moving Averages
Moving Averages are last updated Mar 30, 2026
| Days | MA |
|---|---|
| 10 | 16.94 |
| 20 | 17.34 |
| 30 | 17.59 |
| 50 | 16.88 |
| 100 | 15.21 |
| 200 | 28.12 |
MLTX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.3 billion |
| Earnings/Share ($) | -3.53 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.7189 |
| EPS Estimate Next Year ($) | -3.6461 |
| WallStreet Target Price ($) | 26.7143 |
| Most Recent Quarter |
MoonLake Immunotherapeutics ($MLTX) experiences extreme daily fluctuations in after-hours trading, with potential for future opportunity. Investors holding since September 30 are optimistic for a solid $40 and potential $60 before end of year. Needham raises price target to $25 from $20 with a buy rating. Investors are hoping for a repeat of success at 10:30am. Overall, $MLTX receives a super buy rating.
Updated 2026-02-23 19:00:02